Status:
COMPLETED
Allogenic Cord Blood Transfusion in Patients With Autism
Lead Sponsor:
State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Conditions:
Autism Spectrum Disorder
Autism
Eligibility:
All Genders
3-15 years
Phase:
PHASE1
PHASE2
Brief Summary
Autism is one of those disorders in Autism spectrum disorders (ASD), which characterized by social interaction abnormalities, impaired verbal and non-verbal communication, and repetitive, obsessive be...
Detailed Description
Autism Spectrum Disorders (ASD) are heterogeneous neuro-developed disorders. Autism is the most common disorder of the diseases characterized by dysfunctions in response social interaction and communi...
Eligibility Criteria
Inclusion
- Confirmed diagnosis: autistic type disorder (ASD).
- Systemic speech underdevelopment
- The presence of attention deficit hyperactivity disorder as a comorbid state
- Cognitive impairment
Exclusion
- organic pathology of the brain according to CT, MRI
- the presence of the following diseases in history: heart failure in the stage of decompensation, stroke in history less than 1 year ago, blood diseases;
- decompensation of chronic and endocrinological diseases;
- acute respiratory viral and bacterial infections, period less than 1 month after the acute phase.
- HIV infection, hepatitis B and C.
- oncological diseases, chemotherapy in the anamnesis;
- tuberculosis.
- Severe form of intellectual disability.
- Cerebral palsy.
- epilepsy.
Key Trial Info
Start Date :
October 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03786744
Start Date
October 12 2018
End Date
December 12 2019
Last Update
November 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Centre Dinasty
Samara, Russia, 443095